|Mr. Robert von der Porten||Pres, CEO & Director||N/A||N/A||N/A|
|Mr. James H. Cooke||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Louie Canitano||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Peter Holmes B.A., M.A||VP of Sales||N/A||N/A||50|
|Dr. Daniel A. Kaute||Managing Director of Europe||N/A||N/A||N/A|
MedX Health Corp., a medical device company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in North America, Europe, and Asia. Its skin imaging products include SIMSYS-MoleMate, a skin imaging system for the non-invasive skin screening of moles and lesions. The company's phototherapy products comprise rehab laser console systems, dental laser console systems, acupuncture laser console systems, oralase portable laser probes, acupuncture portable laser probes, MedX home systems, and rehab portable lasers. MedX Health Corp. was incorporated in 1999 and is headquartered in Mississauga, Canada.
MedX Health Corp’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.